Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 314 clinical trials
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …

Georgetown University Medical Center
 (7.9 away)
  • 1875 views
  • 23 Nov, 2020
  • +17 other locations
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US Spanish  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …

Georgetown University Medical Center
 (7.9 away)
  • 268 views
  • 07 Nov, 2020
  • +15 other locations
featured
12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 424 views
  • 08 Nov, 2020
  • 1 location
featured
Disease Modification in Sjogren's Syndrome Measured by Ultrasound

Disease Modification in Sjogren's Syndrome Measured by Ultrasound

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 912 views
  • 08 Nov, 2020
  • 1 location
featured
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)

The Center for Rheumatology and Bone Research
 (8.5 away) Contact site
  • 184 views
  • 23 Nov, 2020
  • 1 location
Treatment of Hemochromatosis

This study will evaluate the effectiveness of a test called MCV in guiding phlebotomy (blood drawing) therapy in patients with hemochromatosis an inherited disorder that causes too much iron to be absorbed by the intestine. The excess damages body tissues, most severely in the liver, heart, pancreas and joints. Because …

National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 4 views
  • 05 Nov, 2020
  • 1 location
Safety Study of Unlicensed Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Children's National Medical Center
 (5.4 away) Contact site
  • 239 views
  • 21 Jun, 2020
  • +61 other locations
Safety Tolerability and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

This study will evaluate the safety, tolerability, and efficacy of Human Cytomegalovirus (CMV) vaccine V160 administered in a 2-dose or 3-dose regimen in healthy seronegative women 16 to 35 years of age. Participants will receive blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day …

Emerson Clinical Research Institute ( Site 0297)
 (4.6 away) Contact site
  • 6476 views
  • 12 Aug, 2019
  • +95 other locations
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of a dual antiplatelet therapy (acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack …

clopidogrel
clot
ck-mb
aspirin
angiography
White Oak Medical Center
 (7.4 away) Contact site
  • 57 views
  • 05 Nov, 2020
  • +187 other locations
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

The purpose of this study is to evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in participants with metastatic or surgically unresectable urothelial cancers that harbor specific FGFR genomic alterations.

adjuvant chemotherapy
dose regimen
erdafitinib
renal function
measurable disease
Georgetown Univ. Medical Center - Lombardi Cancer Center
 (7.9 away) Contact site
  • 40 views
  • 15 Oct, 2020
  • +140 other locations